COUR

Our first-in-class, disease-modifying, targeted therapies are designed to safely regulate and attenuate the immune system. Backed by compelling preclinical and clinical data, our groundbreaking treatments have demonstrated the potential to induce targeted immune tolerance where the body is no longer targeting itself, offering new hope for patients with a range of autoimmune diseases. Our versatile platform technology uses an antigen-specific approach to precisely treat the underlying autoimmune disease to stop inflammatory destruction while preserving the normal immune function. By leveraging the body’s constant endogenous pathway for reinforcing self-tolerance, our technology can be leveraged to target a wide range of immune-mediated diseases.